CHEMOMAB THERAPEUTICS LTD (CMMB) Stock Balance Sheet
USA - NASDAQ:CMMB - US16385C2035 - ADR
2.58 USD
-0.09 (-3.37%)
2.58 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 5.45M | 6.07M | 9.29M | 13.52M | 15.19M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 3.92M | 8.20M | 10.49M | 26.37M | 45.98M | |||
| Receivables | null | null | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 1.25M | 1.77M | 1.11M | 1.85M | 1.53M | |||
| Total Current Assets | 10.61M | 16.04M | 20.90M | 41.74M | 62.69M | |||
| Non-Current Assets | ||||||||
| PPE Net | 217.00K | 539.00K | 695.00K | 590.00K | 700.00K | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 298.00K | 385.00K | 559.00K | 730.00K | 960.00K | |||
| Total Non-Current Assets | 515.00K | 924.00K | 1.25M | 1.32M | 1.66M | |||
| TOTAL ASSETS | 11.13M | 16.96M | 22.15M | 43.06M | 64.35M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 1.05M | 2.55M | 4.32M | 5.06M | 1.31M | |||
| Accounts Payable | 378.00K | 666.00K | 516.00K | 1.69M | 1.34M | |||
| Other Current Liabilities | null | null | null | null | null | |||
| Total Current Liabilities | 1.43M | 3.22M | 4.84M | 6.75M | 2.65M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 0 | 209.00K | 316.00K | 90.00K | 240.00K | |||
| Total Non-Current Liabilities | 0 | 209.00K | 316.00K | 90.00K | 240.00K | |||
| TOTAL LIABILITIES | 1.43M | 3.43M | 5.15M | 6.84M | 2.89M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -108.00M | -102.62M | -88.68M | -63.82M | -36.17M | |||
| Additional Paid In Capital | 117.70M | 116.16M | 105.67M | 101.26M | 97.64M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 0 | 0 | 0 | 0 | 0 | |||
| Treasury Stock | null | null | 0 | -1.22M | null | |||
| Other Shareholders' Equity | null | null | null | null | null | |||
| Shares Outstanding | 16.84M | 15.34M | 577.88K | 591.52K | 579.95K | |||
| Tangible Book Value per Share | 0.0937 | 0.1436 | 4.7863 | 2.4911 | 4.3107 | |||
| Total Shareholders' Equity | 9.70M | 13.54M | 17.00M | 36.22M | 61.47M | |||
| TOTAL LIABILITIES AND EQUITY | 11.13M | 16.96M | 22.15M | 43.06M | 64.35M | |||
| Statistics | ||||||||
| Current Ratio | 7.42 | 4.98 | 4.32 | 6.18 | 23.66 | |||
| Return On Assets (ROA) | -106.26% | -82.20% | -109.34% | -64.21% | -19.39% | |||
| Return On Equity (ROE) | -121.93% | -103.01% | -142.50% | -76.34% | -20.30% | |||
All data in USD , ROIC based on taxRate of 0.21